The Chairman and Chief Executive Officer (CEO) of Krystal Biotech is Krish S. Krishnan. He has spearheaded the corporate, strategic, and financial development of the enterprise since its inception, guiding its transition from a conceptual platform-discovery startup into a fully integrated, commercial-stage global biotechnology leader. Under his leadership, the firm successfully navigated complex clinical trials, secured crucial regulatory approvals from the FDA and international health authorities, and scaled commercial operations globally. His executive vision focuses on leveraging the proprietary non-replicating viral vector platform to develop and commercialize life-changing genetic medicines that address severe conditions with high unmet medical needs across multiple therapeutic areas, including dermatology, respiratory, and oncology.